This activity will review the current state of HTx for pediatric CHD, addressing issues such as mortality risk factors, waitlist mortality, mechanical-support options, and immunosuppression and antibody-mediated rejection. It will also discuss key issues for this population, including psychosocial challenges, rehabilitation goals and future expectations regarding functional outcomes.

This on-demand e-module will provide behavioral care providers with an overview of dialectical behavior therapy (DBT).

Treatment for ADHD, behavior dysregulation, and severe mental illness comes in the form of medication and psychotherapy treatment. Both can be important elements of a comprehensive treatment plan. Data analysis reveals that opportunities for improvement exist for medical practitioners treating children with these disorders. Screening is one of the most common methods for identifying individuals who might benefit from integrated behavioral health services. This web-based activity will provide information on diagnostic criterion for ADHD, best practices, and the appropriate treatment for children with behavioral dysregulation and for youth with a psychotic disorder or a bipolar diagnosis. The appropriate screening tools, medication management and psychosocial support will also be discussed. In addition, information about the importance of follow-up care for children and adolescents who have been prescribed medication, as well as the need for metabolic monitoring for those prescribed antipsychotic medications, will be provided.

This activity will delve into the current landscape and future directions in chronic kidney disease (CKD) management, diagnosis and treatments. Participants will explore recent innovations, including precision medicine approaches and the potential of regenerative medicine and stem cell therapy.